Purchase Short-Term Access
Review: Nonergot dopamine agonists reduce symptoms in the restless legs syndrome but may be discontinued due to adverse events
Shivu Kaushik, MD; Amy R. Blanchard, MD
Annals of Internal Medicine 2008;149:JC4-10.
doi:10.7326/0003-4819-149-8-200810210-02010
Purchase Online access to this article for 24 hours
